Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2025 $ 206,593 $ (197,806) $ (4,376) $ 4,411
Beginning balance, shares at Mar. 31, 2025 1,634,265        
Exercise of employee stock options 23 23
Exercise of employee stock options, shares 8,500        
Employee stock-based compensation 57 57
Foreign currency translation adjustment 806 806
Net loss (1,241) (1,241)
Ending balance, value at Jun. 30, 2025 206,673 (199,047) (3,570) 4,056
Ending balance, shares at Jun. 30, 2025 1,642,765        
Beginning balance, value at Mar. 31, 2025 206,593 (197,806) (4,376) 4,411
Beginning balance, shares at Mar. 31, 2025 1,634,265        
Net loss         (1,775)
Ending balance, value at Sep. 30, 2025 206,733 (199,581) (3,365) 3,787
Ending balance, shares at Sep. 30, 2025 1,649,765        
Beginning balance, value at Jun. 30, 2025 206,673 (199,047) (3,570) 4,056
Beginning balance, shares at Jun. 30, 2025 1,642,765        
Exercise of employee stock options 21 21
Exercise of employee stock options, shares 7,000        
Employee stock-based compensation 39 39
Foreign currency translation adjustment 205 205
Net loss (534) (534)
Ending balance, value at Sep. 30, 2025 206,733 (199,581) (3,365) 3,787
Ending balance, shares at Sep. 30, 2025 1,649,765        
Beginning balance, value at Mar. 31, 2026 207,319 (200,981) (3,243) 3,095
Beginning balance, shares at Mar. 31, 2026 1,799,057        
Proceeds from the At-the-Market sale of common stock, net of offering expenses 55 55
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 23,781        
Proceeds from the sale of common stock, net of offering expenses 3,481 3,481
Proceeds from the sale of common stock, net of offering expenses, shares 2,962,963        
Employee stock-based compensation 58 58
Foreign currency translation adjustment 235 235
Net loss (330) (330)
Ending balance, value at Jun. 30, 2026 210,913 (201,311) (3,008) 6,594
Ending balance, shares at Jun. 30, 2026 4,785,801        
Beginning balance, value at Mar. 31, 2026 207,319 (200,981) (3,243) 3,095
Beginning balance, shares at Mar. 31, 2026 1,799,057        
Net loss         (396)
Ending balance, value at Sep. 30, 2026 211,323 (201,377) (3,332) 6,614
Ending balance, shares at Sep. 30, 2026 5,057,755        
Beginning balance, value at Jun. 30, 2026 210,913 (201,311) (3,008) 6,594
Beginning balance, shares at Jun. 30, 2026 4,785,801        
Proceeds from the At-the-Market sale of common stock, net of offering expenses 312 312
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 265,522        
Exercise of employee stock options and warrants 3 3
Exercise of employee stock options and warrants, shares 2,501        
Employee stock-based compensation 95 95
Employee stock-based compensation, shares 3,931        
Foreign currency translation adjustment (324) (324)
Net loss (66) (66)
Ending balance, value at Sep. 30, 2026 $ 211,323 $ (201,377) $ (3,332) $ 6,614
Ending balance, shares at Sep. 30, 2026 5,057,755